HEPARIN CALCIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for heparin calcium and what is the scope of freedom to operate?
Heparin calcium
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for heparin calcium.
Summary for HEPARIN CALCIUM
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 4 |
| Clinical Trials: | 33 |
| DailyMed Link: | HEPARIN CALCIUM at DailyMed |
Recent Clinical Trials for HEPARIN CALCIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Fayoum University Hospital | N/A |
| University Medical Centre Ljubljana | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for HEPARIN CALCIUM
US Patents and Regulatory Information for HEPARIN CALCIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | CALCIPARINE | heparin calcium | INJECTABLE;INJECTION | 018237-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
